antibacterial resistance

Views & Analysis

Antimicrobial resistance (AMR) is an issue of global concern, killing roughly 1.2 million1 people per year and projected to rise to

Partner Content

Partner Content

Superbugs & Superdrugs USA Conference, Nov 2018

News

Revolution Medicines' pan-RAS(on) inhibitor daraxonrasib has delivered an unprecedented result in pancreatic cancer.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.